Recently, the Association of Passenger Vehicles released sales data for March 2022, of which SAIC-GM-Buick Oncwe achieved sales of 4845 vehicles in March, compared with competitors such as Tiguan L, Oncovi is obviously in poor shape. It seems that after 4529 vehicles in February, Uncovi still has not found a suitable solution.
As one of the best-selling joint venture SUVs, Oncovi sold 30,000 units a month at its peak. After the replacement, it was recently remodeled again, adding the 2022 Encore S. In the case of sitting on on the Uncovi S, Oncover Plus, Oncovey S/Plus and other versions, sales are not as good as before, why is oncover worse and worse?
First of all, looking back at the peak of Oncovi, when some consumers did not have a clear concept of level and positioning, "Chicken Thief" Oncovey called himself a medium-sized SUV, but the minimum match only needed more than 100,000 yuan. Therefore, in a number of medium-sized SUVs, the price advantage of Oncovi is very obvious, and it naturally stands out.
Today, consumers gradually understand that only toyota highlander and Ford Ruijie models can be regarded as medium-sized SUVs in the true sense. The standard for defining a medium-sized SUV can be roughly referred to as a vehicle length of 4800mm-4900mm, a width of 1800mm-1900mm, and a wheelbase of 2800mm-2900mm. According to this standard, Encore can obviously only be regarded as a compact SUV with a large size, that is, an A+ SUV.
So everyone began to rationally compare Oncovi with 200,000-class compact SUVs such as Toyota RAV4 and Honda CR-V, and the so-called price advantage no longer existed. Perhaps for this reason, it has affected the sales of Encore to a certain extent.
Secondly, the failures of the old Oncovi abound, and the related rear axle noise, rear axle oil leakage, transmission oil leakage, transmission slippage, oil seal failure and so on emerge in an endless stream. The 2021 Uncovi has been equipped with a 9-speed automatic transmission as standard, obviously to improve the stability of the 7-speed dual-clutch transmission of the 1.5T model.
However, after a year, many potential users do not even know that Encore has been equipped with a standard 9AT gearbox, indicating that the manufacturer and related dealers do not have enough publicity, potential users still need a certain amount of time to digest, if the future publicity is in place, sales may have a significant increase.
In addition, there is an objective factor is the price, as the saying goes, talking about money does not hurt feelings, 2022 Oncovi current offers are not powerful, there is no price advantage when comparing competitors, plus the popularity is not as good as Volkswagen, Toyota, Honda and other mainstream brands, affecting its sales.
Finally, the strong rise of independent brands, I have to say that consumers once bought joint venture brands to save their minds and have face. However, with the overall performance of domestic cars becoming more and more excellent, consumers are no longer superstitious about joint venture brands. Haval H6, Changan CS75 PLUS, Geely Xingyue L and other independent brand SUVs show their skills. The data shows that in March 2022, Changan CS75 PLUS sold 22,811 vehicles, and the sales volume in the first quarter has exceeded 65,000 units; haval H6 sales have sold 19,303 vehicles, and the sales volume in the first quarter has exceeded 70,000 vehicles... The cold sales of Oncovi will have a certain relationship with the strong rise of independent brands, and it is really difficult to say!
Finally, from the perspective of product strength, the current Oncovi is not only equipped with a higher cost 9AT gearbox, but also has a 48V light mixing blessing, fuel consumption is further reduced, and the popularity of the configuration is quite qualified, and the product has no obvious hard injuries. If the follow-up increase in relevant publicity, the terminal market has greater discounts, I believe that Oncovi still has the opportunity to turn against the wind, what do you think?